...ter utilizes unique microprocessor-controlled filt...tion and detection optics. The filter wheels can b...ous types of applications. With this fluorometer, ...wavelengths. The C&L Dye Fluorometer can measu...
The VICTOR² D fluorometer is suitable for clinical assays based on fluorescence or time-resolved fluorescence from a wide variety of plates.
Zodiac offers end to end transcription services. Zodiac offers two convenient dictation options. Dictations can be either submitted over the phone via toll-free line that you can call 24 hours a day,
Liquid, ready-to-use, bar-coded Olympus reagents are convenient, economical easy-to-use and reliable. This is one of 122 tests standardized for use on the Olympus AU400e, AU640e, AU2700, and AU5400 C
Medicine Products:(Date:11/21/2008)... for preterm labor , , FRIDAY, Nov. 21 (...he switch that activates the uterine muscles for c...ead to therapies for preterm labor. , The mole... the surface of these uterine muscle cells, keepin... But researchers from Dartmouth Medical School in ...
(Date:11/21/2008)...a State University College of Medicine research te...t new layer of regulation in the cell division cyc... the way cancer begins. , Wang, an assistant pro...dicine, said the findings will lead to an improved...design of new drugs that kill cancer cells by inhi...
(Date:11/21/2008)...ire-FirstCall/ -- Heska Corporation,(Nasdaq: HS...rk Society of,Security Analysts, 12th Annual Biot..., 2008 at 1177 Avenue of the Americas, 2nd Floor i...begin at 9:35 a.m. Eastern Time (7:35 a.m.,Mounta...d for two weeks,following the presentation throug...
(Date:11/21/2008)...bout future antibiotic resistance from widespread ...s) -- People with moderate to severe chronic obstr...uce the frequency of exacerbations through a regul...says. , The study, published in the first issu...tory and Critical Care Medicine , found that twice...
Breaking Medicine News(10 mins):Health News:Long-Term Erythromycin Cut COPD Complications 2(Date:11/13/2008)...breaking Research Finds Statins Cut Risk of Heart ...-USNewswire/ -- Cardiovascular Disease,is the lead...althcare,system hundreds of millions of dollars an...for preventing this fatal disease - even among tho...y has found that millions of people could cut thei...
(Date:11/12/2008)... Shares Award with James D. Watson, Marilyn & Jame...Event, ROCKVILLE, Md., Nov. 12 /PRNewswire-USNews...dent of the J. Craig Venter Institute (JCVI), was,...rbor Laboratory (CSHL) on,November 6th at a gala e...ouble Helix Medal along with Dr. James D.,Watson f...
(Date:11/12/2008)...ect-Acting PRT060128 Provides Reversible, High-lev... Onset of Action -, NEW ORLEANS and SOUTH SAN FRA...armaceuticals, a biopharmaceutical company develop...nces in cardiovascular and inflammatory,diseases, ... demonstrate,PRT060128, the Company,s novel anti-p...
(Date:11/12/2008)...t randomized trial of its kind shows no clinically...es for progression of nearsightedness, JACKSONVIL...s wear does,not result in clinically significant a...in children and does not cause relevant increases ...shows. Findings from the,three-year study, the lar...
Breaking Medicine Technology:Seniors Can Be Heartened by New Study on Statins 2J. Craig Venter, Ph.D. Receives Double Helix Medal from Cold Spring Harbor Laboratory 2Portola Announces Data Showing Its Anti-Platelet Drug Inhibits Platelets in Clopidogrel (Plavix(R)) Non-Responders 2Portola Announces Data Showing Its Anti-Platelet Drug Inhibits Platelets in Clopidogrel (Plavix(R)) Non-Responders 3Soft Contact Lenses Do Not Lead to 'Myopic Creep' in Children, Study Shows 2Soft Contact Lenses Do Not Lead to 'Myopic Creep' in Children, Study Shows 3SuperGen Identifies Lead PIM Kinase Inhibitor SGI 1776 That Causes Tumor Regression in AML Xenograft Models 1824 1SuperGen Identifies Lead PIM Kinase Inhibitor SGI 1776 That Causes Tumor Regression in AML Xenograft Models 1824 2Insmed Initiates Clinical Study for Follow on Biologic Version of Neupogen 28R 29 1822 1Insmed Initiates Clinical Study for Follow on Biologic Version of Neupogen 28R 29 1822 2Insmed Initiates Clinical Study for Follow on Biologic Version of Neupogen 28R 29 1822 3Insmed Initiates Clinical Study for Follow on Biologic Version of Neupogen 28R 29 1822 4Sunesis Pharmaceuticals Reports Data from Nonclinical Studies of SNS 032 at the Annual Meeting of the American Association for Cancer Research 1820 1Sunesis Pharmaceuticals Reports Data from Nonclinical Studies of SNS 032 at the Annual Meeting of the American Association for Cancer Research 1820 2Sunesis Pharmaceuticals Reports Data from Nonclinical Studies of SNS 032 at the Annual Meeting of the American Association for Cancer Research 1820 3Sunesis Pharmaceuticals Reports Data from Nonclinical Studies of SNS 032 at the Annual Meeting of the American Association for Cancer Research 1820 4Proof of Concept Study in Second Species Demonstrates Increase in Absorption of Oral B12 Using Emisphere Technology 1818 1Proof of Concept Study in Second Species Demonstrates Increase in Absorption of Oral B12 Using Emisphere Technology 1818 2